On the road again: Experiencing BioTrinity 2021 as our first 2021 live event
COVID-19 has changed how we interact with people and has forced us to re-evaluate how we […]
The ‘Art of API’
The timely availability of high-quality APIs accelerates further investigation by our clients. To meet these pressing API needs, Symeres enables a route-scouting investigation for the API of interest.
Renewal of the GMP certificate for Symeres Prague
This spring, Symeres Prague was audited by the national control authority SÚKL. After this audit, our […]
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer
Earlier this year, our client TOLREMO therapeutics nominated the clinical candidate for a chemical series that […]
Metabolites in Safety Testing (MIST) evaluation
A key goal of clinical trials is to evaluate whether the potential new drug reaches its […]
Symeres, a leading European CRO and CDMO, joins forces with Keensight Capital
Paris (France) – May 25th 2021 We are pleased to let you know that Keensight Capital, […]
The challenging and dynamic world of analytical chemistry
Organic chemistry at Symeres has been proactively accommodating recent developments in drug discovery. Today, we are […]
Ton Vries: The man behind the award
Ton’s days start with a 20 km bike ride from his farm in Drenthe to Symeres […]
Ton Vries Awards 2021 – Winner Announcement
The Ton Vries (Innovation) Award is new within Symeres and is dedicated to the person who, […]
